Pompe disease: a country-wide molecular screening in a cohort of 15,068 study participants

Overall, our study is the first large-scale country-wide selective screening for PD in Russia based on sequencing and GAA activity measurement and providing the most comprehensive overview of genetics of PD in this study population.